Status:
UNKNOWN
tDCS and Psychotherapy for the Treatment of Anxiety Disorders
Lead Sponsor:
University of Coimbra
Conditions:
Anxiety Disorders
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The main goal of the study is to test the efficacy of tDCS in combination with the Unified Protocol for transdiagnostic treatment of emotional disorders, to reduce anxiety symptoms in a mixed anxiety ...
Detailed Description
Participants will be randomly allocated to one of four parallel experimental arms, within a 2X2 factorial design in which two interventions (tDCS and CBT-UP) will be delivered, and assessed according ...
Eligibility Criteria
Inclusion
- Diagnosis of generalized anxiety disorder, specific phobia, panic disorder, agoraphobia, or social anxiety disorder.
- Willing to participate and to give written informed consent
Exclusion
- Contra-indications to tDCS use:
- Presence of a cardiac or neurological condition
- Metallic implants
- If contact with scalp is not possible
- Have had a head injury resulting in a loss of consciousness that has required further investigation
- History of seizures
- Epilepsy or a history of epilepsy
- Past adverse effects with non-invasive stimulation treatments
- Current diagnosis of another psychiatric disorder (except for depression, as long as secondary diagnosis), psychoactive medication or psychological treatment
- Left-handedness
- Pregnancy
- Skin condition on the stimulation target area
- Recreational drug use
Key Trial Info
Start Date :
January 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04453631
Start Date
January 3 2023
End Date
July 1 2024
Last Update
May 20 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.